Trials / Completed
CompletedNCT01306409
Neocytolysis in the Treatment of Renal Anemia With Erythropoieses Stimulating Agents (ESA)
Neocytolysis in the Treatment of Renal Anemia With Erythropoieses Stimulating Agents
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- University Hospital, Basel, Switzerland · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to gain information on reticulocyte neocytolysis in patients treated with ESA with regard to different types of ESA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | cera, darbepoetin, epoetin-beta | Epoetin once/ 2wk, cera once/ month, darbepoetin once/ 2wk |
| DRUG | ESA | Sequential application of three different ESA |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2011-07-01
- Completion
- 2011-10-01
- First posted
- 2011-03-01
- Last updated
- 2011-10-19
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT01306409. Inclusion in this directory is not an endorsement.